We are live on ! Find out more
MIM

Monashee Investment Management Portfolio holdings

AUM $184M
1-Year Est. Return 197.43%
This Fund
S&P 500
This Quarter Est. Return
+0.64%
1 Year Est. Return
+197.43%
3 Year Est. Return
+447.04%
5 Year Est. Return
+479.31%
10 Year Est. Return
+5,610.42%
AUM
$650M
AUM Growth
-$107M
Cap. Flow
-$73.7M
Cap. Flow %
-11.34%
Top 10 Hldgs %
28.5%
Holding
529
New
249
Increased
8
Reduced
22
Closed
155

Top Buys

Rank Stock Value
1
BEAM icon
Beam Therapeutics
BEAM
+$25.6M
2
PSFE icon
Paysafe
PSFE
+$12.2M
3
VIEW
View, Inc. Class A Common Stock
VIEW
+$11.9M
4
OUST icon
Ouster
OUST
+$9.91M
5
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
+$8.09M

Top Sells

Rank Stock Value
1
VTI icon
Vanguard Morningstar Total Stock Market ETF
VTI
+$53.1M
2
SGTX
Sigilon Therapeutics, Inc. Common Stock
SGTX
+$27M
3
QTRX icon
Quanterix
QTRX
+$20.3M
4
SPRU icon
Spruce Power Holding Corp
SPRU
+$14.9M
5
SNRHU
Senior Connect Acquisition Corp. I Unit
SNRHU
+$10.3M

Sector Composition

Rank Sector Weight
1 Healthcare 27.3%
2 Financials 11.86%
3 Technology 7.97%
4 Industrials 4.89%
5 Communication Services 3.88%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SA
426
Seabridge Gold
SA
$3.36B
– –
-34,000
Closed -$716K
SKIN icon
427
SkinHealth Systems
SKIN
$83.3M
– –
-99,993
Closed -$1.13M
SNDX icon
428
Syndax Pharmaceuticals
SNDX
$1.82B
– –
-40,000
Closed -$890K
SPRY icon
429
ARS Pharmaceuticals
SPRY
$587M
– –
-60,000
Closed -$2.78M
STEM icon
430
Stem
STEM
$50.9M
– –
-3,440
Closed -$1.41M
STOK icon
431
Stoke Therapeutics
STOK
$2.08B
– –
-20,000
Closed -$1.24M
STRO icon
432
Sutro Biopharma
STRO
$423M
– –
-7,500
Closed -$1.63M
VTGN icon
433
VistaGen Therapeutics
VTGN
$11.7M
– –
-9,722
Closed -$566K
WGS icon
434
GeneDx Holdings
WGS
$2.32B
– –
-12,121
Closed -$4.42M
LOGC
435
DELISTED
ContextLogic
LOGC
– –
-8,833
Closed -$4.83M
TECX
436
Tectonic Therapeutic
TECX
$639M
– –
-2,457
Closed -$411K
ONC
437
BeOne Medicines Ltd
ONC
$40.6B
– –
-18,600
Closed -$4.81M
MKFG
438
DELISTED
Markforged Holding Corporation
MKFG
– –
-10,000
Closed -$1.08M
TCS
439
DELISTED
THE CONTAINER STORE GROUP, INC.
TCS
– –
-3,333
Closed -$477K
CERE
440
DELISTED
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
– –
-200,000
Closed -$3.32M
COOLU
441
DELISTED
Corner Growth Acquisition Corp. Unit
COOLU
– –
-200,000
Closed -$2.09M
MRNS
442
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
– –
-100,000
Closed -$1.22M
FSR
443
DELISTED
Fisker Inc.
FSR
– –
-400,000
Closed -$5.86M
ALTUU
444
DELISTED
Altitude Acquisition Corp Unit
ALTUU
– –
-160,000
Closed -$1.66M
PNT
445
DELISTED
POINT Biopharma Global Inc. Common Stock
PNT
– –
-47,271
Closed -$658K
VIIAU
446
DELISTED
7GC & Co Holdings Unit
VIIAU
– –
-250,000
Closed -$2.64M
CFIVU
447
DELISTED
CF Acquisition Corp. IV Unit
CFIVU
– –
-500,000
Closed -$5.14M
CZOO
448
DELISTED
Cazoo Group Ltd
CZOO
– –
-100
Closed -$2.36M
CCV.U
449
DELISTED
Churchill Capital Corp V Units, each consisting of one share of Class A common stock, and one-fourth of one redeemable warrant
CCV.U
– –
-50,000
Closed -$525K
SYNH
450
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
– –
-100,000
Closed -$6.81M
16 17
18
19 20

Similar funds

SWMG
Sard Wealth Management Group Atlanta, Georgia $184M AUM 11.26% 1-Year Est. Return
IFPL
Investments & Financial Planning LLC Lexington, Kentucky $184M AUM 17.7% 1-Year Est. Return
RFG
RFP Financial Group Atlanta, Georgia $184M AUM 16.06% 1-Year Est. Return
NAM
Nutshell Asset Management Sevenoaks, United Kingdom $184M AUM 2.02% 1-Year Est. Return
GCGM
General Catalyst Group Management Cambridge, Massachusetts $184M AUM 50.45% 1-Year Est. Return
PSAMP
P. Schoenfeld Asset Management (PSAM) New York $184M AUM 97.09% 1-Year Est. Return
GCA
GSI Capital Advisors Newport Beach, California $184M AUM 5.17% 1-Year Est. Return
IVGAV
Index Venture Growth Associates V St. Helier, Jersey $184M AUM

Monashee Investment Management's Q1 2021 Portfolio in Review

As of Q1 2021, Monashee Investment Management held 529 positions worth $650M, down 14% from $757M the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Monashee Investment Management withdrew a net $73.7M in Q1 2021, closing 155 positions and reducing 22 holdings. Its most notable exit was Sigilon Therapeutics, Inc. Common Stock, an estimated $27M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 27% of assets, down from 30% a quarter earlier, followed by Financials and Technology.

Against the trend, Monashee Investment Management opened a new position in Beam Therapeutics worth $21.5M.

  • Monashee Investment Management's largest Q1 2021 buy was Beam Therapeutics: 268,820 shares worth $21.5M.
  • Monashee Investment Management added most to View, Inc. Class A Common Stock in Q1 2021, an estimated $11.9M increase.
  • Monashee Investment Management's biggest Q1 2021 reduction was Vanguard Morningstar Total Stock Market ETF, cutting an estimated $53.1M.
  • Monashee Investment Management fully exited Sigilon Therapeutics, Inc. Common Stock in Q1 2021, selling an estimated $27M.
  • Monashee Investment Management's ten largest holdings make up 28% of its $650M portfolio in Q1 2021.
  • Monashee Investment Management opened 249 new positions and closed 155 in Q1 2021.
  • Monashee Investment Management's portfolio value fell 14% quarter-over-quarter to $650M.

Based on Monashee Investment Management's 13F filing for Q1 2021, filed 14 May 2021.